DrugPatentWatch Database Preview

ASTRAMORPH PF Drug Profile

« Back to Dashboard

Which patents cover Astramorph Pf, and when can generic versions of Astramorph Pf launch?

Astramorph Pf is a drug marketed by Fresenius Kabi Usa and is included in four NDAs.

The generic ingredient in ASTRAMORPH PF is morphine sulfate. There are twenty-three drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Astramorph Pf

A generic version of ASTRAMORPH PF was launched as morphine sulfate by HOSPIRA on December 13^th, 2019.

Summary for ASTRAMORPH PF

US Patents:	0
Applicants:	1
NDAs:	4
Bulk Api Vendors:	17
Clinical Trials:	2
Patent Applications:	7,779
Formulation / Manufacturing:	see details
DailyMed Link:	ASTRAMORPH PF at DailyMed

Recent Clinical Trials for ASTRAMORPH PF

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Institute on Drug Abuse (NIDA)	N/A
Vanderbilt University Medical Center	N/A
National Heart, Lung, and Blood Institute (NHLBI)	Phase 4

See all ASTRAMORPH PF clinical trials

Synonyms for ASTRAMORPH PF

(-)-(etorphine)

(-)-Morphine

(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(-)Morphine sulfate

(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18),15-tetraene-10,14-diol

(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0;{1,13}.0;{5,17}.0;{7,18}]octadeca-7(18),8,10,15-tetraene-10,14-diol

(1S,5R,13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol

(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol

(5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL

(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol

(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(5alpha,6beta)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol

(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol

(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL

(Morphine)

(morphine) 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol

1325730-46-8

17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol

2-{4-[2,4-diamino-6-pteridinylmethyl(methyl)amino]phenylcarboxamido}pentanedioic acid(morphine)

3-(4-Hydroxy-phenyl)-1-propyl-piperidine-3-carboxylic acid ethyl ester

4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol

4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol ; HydroChloride

4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol ;sulphate salt(morphine)

4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol,sulfate(Morphinesulfate)

4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol((Morphine))

4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(morphine sulfate)

4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(morphine)

4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(Morphine)(HCl)

4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diolMorphine

4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol

4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol (morphine)

4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(Morphine)

4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol

47106-99-0

57-27-2

6-tert-Butyl-3-methyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine

6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Morphine)

6211-15-0 (sulfate (2:1) (salt) pentahydrate)

64-31-3 (sulfate (2:1) (salt) anhydrous)

7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol

7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol(morphine)

76I7G6D29C

8053-16-5

85201-37-2

863713-90-0

9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4a,5,7a,8-tetrahydro-12-methyl-

9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4alpha,5,7alpha,8-tetrahydro-12-methyl-

Aguettant

AKOS015966554

AN-23579

AN-23737

Avinza

BDBM50000092

BIDD:GT0147

BQJCRHHNABKAKU-KBQPJGBKSA-N

C01516

CCRIS 5762

CHEBI:17303

CHEMBL3978843

CHEMBL70

Cube juice

D-(-)-Morphine

D08233

DB00295

DEA No. 9300

DepoDur

Dimorf

Dinamorf

Dolcontin

Dreamer

DTXSID9023336

Dulcontin

Duramorph

Duramorph PF

Duromorph

EINECS 200-320-2

Epimorph

Epitope ID:116646

GTPL1627

Hard stuff

Hocus

HSDB 2134

Infumorph

Kadian

l-Morphine

LS-91748

M-Eslon

M.O.S

Meconium

methyl[?]diol

MOI

Morfina

Morfina [Italian]

Morfina Dosa (TN)

Morphia

Morphin

Morphin [German]

Morphina

Morphina [Italian]

Morphinan-3,6-alpha-diol, 7,8-didehydro-4,5-alpha-epoxy-17-methyl-

Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5..alpha.,6.alpha.)-

Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-

Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-, (5alpha,6alpha)-

morphine

Morphine (BAN)

Morphine [BAN]

Morphine 0.1 mg/ml in Methanol

Morphine 1.0 mg/ml in Methanol

Morphine Anhydrate

Morphine Extra-Forte

Morphine Forte

Morphine H.P

Morphine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material

MORPHINE SULFATE

MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE

Morphine;4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol

Morphinism

Morphinum

Morphitec

Morphium

Morpho

Moscontin

MS Contin

Ms Emma

MS/L

MS/S

Mscontin, Oramorph

MSIR

Nepenthe

NSC11441

OMS Concentrate

Oramorph

Oramorph SR

Ospalivina

Rescudose

RMS

RMS Uniserts

Roxanol

Roxanol 100

Roxanol UD

SCHEMBL2997

SDZ 202-250

SDZ202-250

Sevredol

Statex Drops

Statex SR

Substitol (TN)

UNII-1M5VY6ITRT component BQJCRHHNABKAKU-KBQPJGBKSA-N

UNII-76I7G6D29C

Unkie

ZINC3812983

US Patents and Regulatory Information for ASTRAMORPH PF

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fresenius Kabi Usa	ASTRAMORPH PF	morphine sulfate	INJECTABLE;INJECTION	071050-001	Oct 7, 1986		DISCN	No	No
Fresenius Kabi Usa	ASTRAMORPH PF	morphine sulfate	INJECTABLE;INJECTION	071053-001	Oct 7, 1986		DISCN	No	No
Fresenius Kabi Usa	ASTRAMORPH PF	morphine sulfate	INJECTABLE;INJECTION	071051-001	Oct 7, 1986		DISCN	No	No
Fresenius Kabi Usa	ASTRAMORPH PF	morphine sulfate	INJECTABLE;INJECTION	071052-001	Oct 7, 1986		DISCN	No	No